<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hopfner F</submitter><funding>NIA NIH HHS</funding><funding>Deutsche Gesellschaft für Parkinson und Bewegungsstörungen</funding><funding>Medical Research Council</funding><funding>NINDS NIH HHS</funding><funding>Else Kröner-Fresenius-Stiftung</funding><pagination>2110-2121</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10052809</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>37(10)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Multiple System Atrophy is a rare neurodegenerative disease with alpha-synuclein aggregation in glial cytoplasmic inclusions and either predominant olivopontocerebellar atrophy or striatonigral degeneration, leading to dysautonomia, parkinsonism, and cerebellar ataxia. One prior genome-wide association study in mainly clinically diagnosed patients with Multiple System Atrophy failed to identify genetic variants predisposing for the disease.&lt;h4>Objective&lt;/h4>Since the clinical diagnosis of Multiple System Atrophy yields a high rate of misdiagnosis when compared to the neuropathological gold standard, we studied only autopsy-confirmed cases.&lt;h4>Methods&lt;/h4>We studied common genetic variations in Multiple System Atrophy cases (N = 731) and controls (N = 2898).&lt;h4>Results&lt;/h</pubmed_abstract><journal>Movement disorders : official journal of the Movement Disorder Society</journal><pubmed_title>Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy.</pubmed_title><pmcid>PMC10052809</pmcid><funding_grant_id>U54 NS110435</funding_grant_id><funding_grant_id>U24 NS120854</funding_grant_id><funding_grant_id>P30 AG010124</funding_grant_id><funding_grant_id>P50 AG005136</funding_grant_id><funding_grant_id>U01 AG016976</funding_grant_id><funding_grant_id>P30 AG066509</funding_grant_id><funding_grant_id>U24 AG021886</funding_grant_id><funding_grant_id>U19 AG062418</funding_grant_id><funding_grant_id>P30 AG072977</funding_grant_id><funding_grant_id>U01 AG032984</funding_grant_id><funding_grant_id>K08 AG065463</funding_grant_id><funding_grant_id>P01 AG066597</funding_grant_id><funding_grant_id>U24 AG041689</funding_grant_id><funding_grant_id>P50 NS053488</funding_grant_id><funding_grant_id>P30 AG072979</funding_grant_id><funding_grant_id>MR/L016451/1</funding_grant_id><pubmed_authors>Molina Porcel L</pubmed_authors><pubmed_authors>Halliday G</pubmed_authors><pubmed_authors>Peters A</pubmed_authors><pubmed_authors>Ruf VC</pubmed_authors><pubmed_authors>Trojanowski JQ</pubmed_authors><pubmed_authors>Stadelmann C</pubmed_authors><pubmed_authors>Muller U</pubmed_authors><pubmed_authors>Neumann M</pubmed_authors><pubmed_authors>Alzheimer's Disease Genetics Consortium</pubmed_authors><pubmed_authors>Schellenberg GD</pubmed_authors><pubmed_authors>Beach T</pubmed_authors><pubmed_authors>Hollerhage M</pubmed_authors><pubmed_authors>Newell KL</pubmed_authors><pubmed_authors>Matej R</pubmed_authors><pubmed_authors>Helbig I</pubmed_authors><pubmed_authors>Wszolek ZK</pubmed_authors><pubmed_authors>Irwin DJ</pubmed_authors><pubmed_authors>Desplats P</pubmed_authors><pubmed_authors>Hoglinger G</pubmed_authors><pubmed_authors>Aguzzi A</pubmed_authors><pubmed_authors>Pendziwiat M</pubmed_authors><pubmed_authors>Xie T</pubmed_authors><pubmed_authors>McKeith I</pubmed_authors><pubmed_authors>Hopfner F</pubmed_authors><pubmed_authors>Evsyukov V</pubmed_authors><pubmed_authors>Ghetti B</pubmed_authors><pubmed_authors>White CL</pubmed_authors><pubmed_authors>Flanagan ME</pubmed_authors><pubmed_authors>Selvackadunco S</pubmed_authors><pubmed_authors>Cheshire WP</pubmed_authors><pubmed_authors>Uitti RJ</pubmed_authors><pubmed_authors>Mollenhauer B</pubmed_authors><pubmed_authors>Trenkwalder C</pubmed_authors><pubmed_authors>Marti MJ</pubmed_authors><pubmed_authors>Dickson D</pubmed_authors><pubmed_authors>Lee EB</pubmed_authors><pubmed_authors>Kovacs GG</pubmed_authors><pubmed_authors>Svenningsson P</pubmed_authors><pubmed_authors>Mackenzie I</pubmed_authors><pubmed_authors>Reimann R</pubmed_authors><pubmed_authors>Thomas A</pubmed_authors><pubmed_authors>Huitinga I</pubmed_authors><pubmed_authors>Kuhlenbaumer G</pubmed_authors><pubmed_authors>Franke A</pubmed_authors><pubmed_authors>Rajput A</pubmed_authors><pubmed_authors>van Deerlin V</pubmed_authors><pubmed_authors>Tietz AK</pubmed_authors><pubmed_authors>Gearing M</pubmed_authors><pubmed_authors>Rabano A</pubmed_authors><pubmed_authors>Koga S</pubmed_authors><pubmed_authors>Gelpi E</pubmed_authors><pubmed_authors>Seeley W</pubmed_authors><pubmed_authors>Herms J</pubmed_authors><pubmed_authors>Scott WK</pubmed_authors><pubmed_authors>Simuni T</pubmed_authors><pubmed_authors>Glass JD</pubmed_authors><pubmed_authors>Frosch MP</pubmed_authors><pubmed_authors>Keene DC</pubmed_authors><pubmed_authors>Ximelis T</pubmed_authors><pubmed_authors>Grinberg LT</pubmed_authors><pubmed_authors>Ross OA</pubmed_authors><pubmed_authors>Attems J</pubmed_authors><pubmed_authors>Ellinghaus D</pubmed_authors><pubmed_authors>Troakes C</pubmed_authors><pubmed_authors>Yebenes J</pubmed_authors><pubmed_authors>Levin J</pubmed_authors><pubmed_authors>Deuschl G</pubmed_authors><pubmed_authors>Duyckaerts C</pubmed_authors><pubmed_authors>Mclean C</pubmed_authors><pubmed_authors>van Gerpen JA</pubmed_authors><pubmed_authors>Pantelyat A</pubmed_authors><pubmed_authors>Beller A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy.</name><description>&lt;h4>Background&lt;/h4>Multiple System Atrophy is a rare neurodegenerative disease with alpha-synuclein aggregation in glial cytoplasmic inclusions and either predominant olivopontocerebellar atrophy or striatonigral degeneration, leading to dysautonomia, parkinsonism, and cerebellar ataxia. One prior genome-wide association study in mainly clinically diagnosed patients with Multiple System Atrophy failed to identify genetic variants predisposing for the disease.&lt;h4>Objective&lt;/h4>Since the clinical diagnosis of Multiple System Atrophy yields a high rate of misdiagnosis when compared to the neuropathological gold standard, we studied only autopsy-confirmed cases.&lt;h4>Methods&lt;/h4>We studied common genetic variations in Multiple System Atrophy cases (N = 731) and controls (N = 2898).&lt;h4>Results&lt;/h</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2026-05-29T01:57:56.953Z</modification><creation>2025-04-04T03:00:49.567Z</creation></dates><accession>S-EPMC10052809</accession><cross_references><pubmed>35997131</pubmed><doi>10.1002/mds.29164</doi></cross_references></HashMap>